Rice producers in the United States need effective herbicides to control problematic weeds. Previous research has demonstrated that acetochlor can provide in-season weed control in rice; however, undesirable injury is common. Thus, trials were initiated in 2020 and 2021 to evaluate 1) rice cultivar tolerance to microencapsulated (ME) acetochlor with the use of a fenclorim seed treatment at 2.5 g ai kg−1 of seed; 2) a dose-response of a fenclorim seed treatment with ME acetochlor; and 3) rice tolerance to fenclorim and ME acetochlor under cool, wet conditions. For all trials, acetochlor was applied delayed-preemergence (4 to 7 d after planting). In the dose-response trials and in the presence of acetochlor, the fenclorim seed treatment rate of 2.5 g ai kg−1 reduced rice injury and increased rice plant heights and shoot numbers relative to acetochlor without fenclorim, and plant heights and shoot numbers were comparable to those of the nontreated control in all evaluations. In the cultivar screening, 14 of 16 cultivars exhibited <20% injury with acetochlor at 1,260 g ai ha−1 and fenclorim at 2.5 g ai kg−1 2 wk after emergence (WAE) at the Pine Tree Research Station (PTRS). At the Rice Research and Extension Center (RREC) 2 and 4 WAE and at PTRS 4 WAE, all cultivars exhibited <20% injury with acetochlor and fenclorim. The fenclorim seed treatment in the presence of acetochlor provided comparable rice plant height, shoot numbers, groundcover, and rough rice yield to that of the nontreated control. Under cool, wet conditions, rice injury without fenclorim ranged from 15% to 60% with acetochlor at 1,050 g ai ha−1, whereas injury from acetochlor with the fenclorim seed treatment ranged from 0% to 20%. Based on the results of these experiments, the fenclorim seed treatment appears to safen an assortment of rice cultivars from injury caused by ME acetochlor.

Nutrition demands in aquaculture can be realized through quality aquafeeds as compounded diets that contribute to the growth and health of aquaculture species. Functional additives in feed, notably probiotics, prebiotics, and their admixture synbiotics, have been recently recognized for their biotherapeutic role as immunostimulants capable of conferring disease resistance, stress tolerance, and gastrointestinal health; counteracting the negative effects of anti-nutrients, pathogenic prevalence, and antimicrobials in finfish aquaculture. Formulated diets based on probiotics, prebiotics, and as a supplemental combination for synbiotics can significantly influence fish gut microbiomes, establishing the modalities of microbial dynamics to maximize host-associated benefits. These microbial functional-feed supplements are acclaimed to be biocompatible, biodegradable, and safe for dietary consumption as well as the environment. In fed fish aquaculture, prebiotic appended probiotic diet ‘synbiotic’ has propounded larger attention for its additional health and nutritional benefits. Synbiotic, prebiotic, and probiotic usage as functional feeds for finfish aquaculture thus provides promising prospects. Developing trends in their intended application are reviewed here forth.

Many problematic weeds have evolved resistance to herbicides in mid-southern U.S. rice fields. With the lack of new effective herbicides, rice producers seek alternatives that are currently not labeled for rice production. Inhibitors of very-long chain fatty acid elongase (VLCFA) are currently not labeled for use with U.S. rice crops but are labeled for use in other U.S. row cropping systems and rice production in Asia. Previous research has demonstrated the utility of VLCFA inhibitors for weed control in rice; however, these herbicides induce variable amounts of injury to the crop when applied early in the growing season. Experiments were initiated in 2020 and 2021 at the Rice Research and Extension Center near Stuttgart, AR, to evaluate rice tolerance and weed control with acetochlor and seed treatment with a herbicide safener, fenclorim. Three rates of a microencapsulated formulation of acetochlor (630, 1,260, and 1,890 g ai ha−1), four application timings (preemergence, PRE; delayed-preemergence, DPRE; spiking; and 1-leaf), and without or with the fenclorim seed treatment (2.5 g kg−1 of seed) were used to evaluate rice tolerance, weedy rice control, and barnyardgrass control. Acetochlor applied DPRE at 1,260 g ai ha−1 provided better weedy rice and barnyardgrass control than applications at the 1-leaf stage at the same rate. Acetochlor rates of 1,260 and 1,890 g ai ha−1 reduced barnyardgrass and weedy rice densities by more greater than the 630 g ai ha−1 rate. The fenclorim seed treatment did not influence weedy rice or barnyardgrass control but did reduce injury for DPRE acetochlor applications. Based on these results, acetochlor can be safely applied to rice DPRE (≤19% injury) at 1,260 g ai ha−1 when the seed is treated with fenclorim, leading to ≥88% barnyardgrass and ≥45% weedy rice control 28 d after treatment.

Pomegranate peel is an agro-industrial residue obtained after fruit processing with high total polyphenol (TP) content, making it an attractive by-product for its reuse. Pomegranate peel extract (PPE) and its bioactive compounds have shown positive effects on obesity models. Effects on favouring mitochondrial biogenesis and function have also been described. However, once phenolic compounds are extracted, their stability can be affected by diverse factors. Microencapsulation could improve PPE stability, allowing its incorporation into functional foods. Nevertheless, studies on the potential biological effects of PPE microparticles (MPPE) in obesity models are lacking. This study aims to evaluate the effect of MPPE on brown adipose tissue (BAT) mitochondrial structure and function and metabolic alterations related to obesity in mice fed a high-fat diet (HFD). PPE was microencapsulated by spray drying using inulin (IN) as a wall material and physically–chemically characterised. Eight-week-old male C57BL/6J mice (n 40) were randomly distributed into five groups: control diet (CD), HFD, HFD + IN, HFD + PPE (50 mg/kg per d TP) and HFD + MPPE (50 mg/kg per d TP), for 14 weeks. A glucose tolerance test and indirect calorimetry were conducted. Blood and adipose tissue samples were obtained. MPPE supplementation prevented HFD-induced body weight gain (P < 0·001), fasting glycaemia (P = 0·007) and total cholesterol rise (P = 0·001). MPPE resulted in higher BAT mitochondrial complex IV activity (P = 0·03) and prevented HFD-induced mitochondrial cristae alteration (P = 0·02). In conclusion, MPPE prevented HFD-induced excessive body weight gain and associated metabolic disturbances, potentially by activating complex IV activity and preserving mitochondrial cristae structure in BAT in mice fed with a HFD.

The in vivo effects of administering free and microencapsulated Lactobacillus plantarum LIP-1 cells (2·0×109 colony-forming units/d) were evaluated in high-fat-diet-induced hyperlipidaemic rats. Results from real-time quantitative PCR targeting to LIP-1 cells showed a higher colon colonisation count of LIP-1 in the rats receiving microencapsulated cells compared with free cells (P<0·05). Moreover, the microencapsulated LIP-1 treatment resulted in a more obvious lipid-lowering effect (P<0·05). Meanwhile, their faecal samples had significantly less lipopolysaccharide-producing bacteria (especially Bilophila, Sutterella and Oscillibacter) and mucosa-damaging bacteria (Bilophila and Akkermansia muciniphila), whereas significantly more SCFA-producing bacteria (P<0·05) (namely Lactobacillus, Alloprevotella, Coprococcus, Eubacterium and Ruminococcus) and bacteria that potentially possessed bile salt hydrolase activity (Bacteroides, Clostridium, Eubacterium and Lactobacillus), and other beneficial bacteria (Alistipes and Turicibacter). Further, Spearman’s correlation analysis showed significant correlations between some of the modulated gut bacteria and the serum lipid levels. These results together confirm that microcapsulation enhanced the colon colonisation of LIP-1 cells, which subsequently exhibited more pronounced effects in improving the gut microbiota composition of hyperlipidaemic rats and lipid reduction.

Field and column experiments were conducted to determine the effect of controlled release formulations on weed control and leaching of alachlor and metribuzin on a Plainfield sand. Controlled release formulations including two starch encapsulations of both herbicides and a microencapsulation of alachlor were compared to emulsifiable concentrate and dry flowable formulations of alachlor and metribuzin, respectively. Herbicide movement was measured in laboratory columns and in the field throughout two growing seasons to a soil depth of 91 cm. Soybean injury and weed control were monitored. No significant differences in herbicide movement between starch-encapsulated and emulsifiable concentrate formulations were observed in either field or column experiments. Microencapsulation resulted in the greatest retention of alachlor in the soil surface in field and columns. Compared to the dry flowable formulation, starch encapsulation did not affect metribuzin distribution in the field but reduced leaching in columns. Controlled release formulations did not result in significant differences in weed control and soybean injury compared to the emulsifiable concentrate alachlor and dry flowable metribuzin formulations. Starch encapsulations had a limited effect on alachlor and metribuzin movement. Degradation appeared to be the primary mechanism for herbicide dissipation while leaching losses were minor.

Laboratory and field research was conducted to determine the influence of winter wheat (Triticum aestivum L.) stubble on weed control and the dissipation of emulsifiable concentrate formulations (EC) of metolachlor [2-chloro-N-(2-ethyl-6-methylphenyl)-N-(2-methoxy-1-methylethyl) acetamide], alachlor [2-chloro-N-(2,6-diethylphenyl)-N-(methoxymethyl)acetamide], and acetochlor [2-chloro-N-(ethoxymethyl)-N-(2-ethyl-6-methylphenyl)acetamide]; and microencapsulated formulations (ME) of alachlor and acetochlor. EC metolachlor provided better weed control than EC alachlor when applied 28 days before planting sorghum (Sorghum bicolor L.) and similar weed control when applied at 1 or 14 days before planting. This difference was attributed to more rapid EC alachlor dissipation. The order of relative herbicide persistence at 24 C and 33% (w/w) soil moisture in a silty clay loam was ME acetochlor = ME alachlor > EC metolachlor > EC acetochlor = EC alachlor. Acetanilide degradation was affected more by increasing temperature from 15 to 24 C than by increasing soil moisture from 15 to 33%. More herbicide was washed from overwintered than fresh straw in the first 1 cm of simulated rainfall. In the first simulated rainfall event, more herbicide was removed from straw that had been dry than wet at application, but the amount of herbicide remaining on dry and wet straw was similar after four events. Formulation generally did not affect herbicide wash-off.

Scanning electron microscopy (SEM) was used to study alachlor microcapsule morphology and the effects of straw age and moisture on herbicide release. Microcapsule diameter in the formulation ranged from 2 to 15 μm. The polyurea encapsulating material was stable in water over time. Diffusion was suggested as the primary mode of alachlor release, with diffusion rate controlled by herbicide and salt concentration gradients between the microcapsule and the surrounding aqueous solution. Alachlor release was promoted by drying the microcapsules before addition to water. Microcapsule morphology was unchanged 48 h after application to dry straw, and microcapsules did not appear to adhere to the straw surface. Microcapsules applied to overwintered wet straw were shriveled at 48 h after treatment, indicating herbicide loss. Capsule walls were broken and appeared brittle after application to fresh wet straw. Organic constituents of the fresh straw cuticle may affect capsule wall integrity.

Corn inbreds are often more sensitive to herbicides than hybrids. Field experiments were conducted with three corn inbreds to (1) evaluate inbred sensitivity to the acetamide herbicides acetochlor, dimethenamid, flufenacet, and metolachlor, (2) compare the effects of various crop safeners in combination with acetochlor and metolachlor, and (3) measure the effect of herbicide microencapsulation on acetochlor injury. Herbicides were applied preemergence at the registered rate and at two, three, or four times the registered rate in corn. Injury ratings, plant population, and the percentage of plants showing acetamide injury symptoms were used to measure herbicide effect. The inbreds ‘Mo17’ and ‘Great Lakes 15’ (GL15) were sensitive to acetamide injury. Reductions in plant population and increases in the injury rating and the percentage of injured plants were caused by acetochlor, dimethenamid, flufenacet, metolachlor, and flufenacet + metribuzin when applied at three times the registered rate. The inbred ‘B73’ was not injured. The safeners benoxacor and dichlormid reduced injury caused by metolachlor. The percentage of plants injured by metolachlor 15 days after treatment (DAT) was lower when benoxacor was the safener compared to dichlormid. By 28 DAT, plants treated with safeners recovered from injury, and there were no differences between the treatments. The safeners dichlormid and furilazole reduced, but did not always eliminate, injury caused by acetochlor applied at three times the registered rate. Microencapsulation of acetochlor reduced injury to GL15. When the safeners dichlormid or furilazole were included in an acetochlor formulation, microencapsulation did not further reduce corn injury.

Mounting evidence showed that bitter-tasting compounds modulate eating behaviour through bitter taste receptors in the gastrointestinal tract. This study aimed at evaluating the influence of microencapsulated bitter compounds on human appetite and energy intakes. A microencapsulated bitter ingredient (EBI) with a core of bitter Gentiana lutea root extract and a coating of ethylcellulose–stearate was developed and included in a vanilla microencapsulated bitter ingredient-enriched pudding (EBIP). The coating masked bitterness in the mouth, allowing the release of bitter secoiridoids in the gastrointestinal tract. A cross-over randomised study was performed: twenty healthy subjects consumed at breakfast EBIP (providing 100 mg of secoiridoids) or the control pudding (CP) on two different occasions. Blood samples, glycaemia and appetite ratings were collected at baseline and 30, 60, 120 and 180 min after breakfast. Gastrointestinal peptides, endocannabinoids (EC) and N-acylethanolamines (NAE) were measured in plasma samples. Energy intakes were measured at an ad libitum lunch 3 h after breakfast and over the rest of the day (post lunch) through food diaries. No significant difference in postprandial plasma responses of gastrointestinal hormones, glucose, EC and NAE and of appetite between EBIP and CP was found. However, a trend for a higher response of glucagon-like peptide-1 after EBIP than after CP was observed. EBIP determined a significant 30 % lower energy intake over the post-lunch period compared with CP. These findings were consistent with the tailored release of bitter-tasting compounds from EBIP along the gastrointestinal tract. This study demonstrated that microencapsulated bitter secoiridoids were effective in reducing daily energy intake in humans.

The aim of this study was to compare low doses of microencapsulated v. pharmacological ZnO in the diet of piglets on growth performance, ileum health status and architecture. One hundred and forty-four piglets weaned at 28 days and divided in 36 pens (two males and two females per pen), received a basal diet (control, Zn at 50 mg/kg) or the basal diet with ZnO at 3000 mg/kg (pZnO), or with lipid microencapsulated ZnO at 150 or 400 mg/kg (mZnO-300 and mZnO-800, respectively). After 14 and 42 days, three pigs per sex per treatment were euthanized to collect the ileum mucosa for immunohistochemistry, histomorphology, inflammatory cytokines and tight junction components gene expression. Data were analyzed with one-way ANOVA. At 0 to 14 days, the pZnO and mZnO-800 groups had greater average daily gain compared with control (P<0.05). Gain to feed ratio (G:F) in the same time interval was higher in pZnO group compared with control thus resulting in higher BW (P<0.05). At day 14, ileum villi height in mZnO-800 pigs was 343 µm v. 309 and 317 µm in control and pZnO, respectively (P<0.01) and villi:crypts ratio (V:C), as well as cells positive to proliferating cell nuclear antigen (PCNA), were greater in all treated groups compared with control (P<0.01). In mZnO-800 group, interferon-γ mRNA was the lowest (P=0.02), and both pharmacological ZnO and mZnO reduced tumor necrosis factor-α protein level (P<0.0001). Compared with pZnO group, mZnO-800 increased occludin and zonula occludens-1 protein level (1.6-fold and 1.3-fold, respectively; P<0.001). At day 42, both groups receiving microencapsulated ZnO had 1.7 kg greater BW than control and did not differ from pZnO group (P=0.01); ileum villi height and V:C ratio were the greatest for pZnO compared with the other groups, whereas PCNA-positive cells were the most numerous in mZnO-800 group (P<0.001). In conclusion, pigs receiving low doses of microencapsulated ZnO had G:F comparable with those receiving pharmacological level of ZnO in the overall post-weaning phase. Moreover, in the first 2 weeks post-weaning, microencapsulated ZnO effect on inflammatory status and ileum structure and integrity was comparable with pharmacological ZnO.

Fish oil n-3 fatty acids (FA) have known health benefits. Microencapsulation stabilises and protects fish oil from oxidation, enabling its incorporation into foods. The aim of the present study was to compare the bioavailability of n-3 FA delivered as two microencapsulated fish oil-formulated powders or fish oil gel capsules (FOGC) taken with a flavoured milk in healthy participants. Formulation 1 (F1) composed of a heated mixture of milk protein–sugar as an encapsulant, and formulation 2 (F2) comprised a heated mixture of milk protein–sugar–resistant starch as an encapsulant. Participants consumed 4 g fish oil (approximately 1·0 g EPA and DHA equivalent per dose). Bioavailability was assessed acutely after ingestion of a single dose by measuring total plasma FA composition over a period of 48 h (n 14) using a randomised cross-over design, and over the short term for a period of 4 weeks using an unblinded parallel design (after daily supplementation) by measuring total plasma and erythrocyte FA composition at baseline and at 2 and 4 weeks (n 47). In the acute study, F1 greatly increased (% Δ) plasma EPA and total n-3 FA levels at 2 and 4 h and DHA levels at 4 h compared with FOGC. The time to reach maximal plasma values (Tmax) was shorter for F1 than for FOGC or F2. In the short-term study, increases in plasma and erythrocyte n-3 FA values were similar for all treatments and achieved an omega-3 index in the range of 5·8–6·3 % after 4 weeks. Overall, the results demonstrated human bioequivalence for microencapsulated fish oil powder compared with FOGC.

Introduction. Polyphenols have received significant attention in recent years due to their antioxidant capacity and their significant role in disease prevention. Cocoa is one of the major naturally occurring sources of antioxidants, particularly of polyphenolic compounds. Materials and methods. Gelatin nanoparticles loaded with a cocoa-derived polyphenolic extract were synthesized by nanoprecipitation. The nanoparticle synthesis was performed using a central composite experimental design that allowed for the assessment of how gelatin concentration and surfactant concentration (Tween 80) affected the hydrodynamic diameter and polydispersity of the particles. The nanoparticles were characterized using dynamic light scattering (DLS), assessments of zeta potential, scanning electron microscopy (SEM) and Fourier transform infrared spectroscopy (FT-IR). Results. The analyses demonstrated that the nanoparticles examined exhibited hydrodynamic diameters of (100 to 400) nm, polydispersity indices of less than 0.2 and average zeta potential values of 29–33 mV. SEM images revealed that most nanoparticles were spherical and uniform in morphology, with average sizes less than 250 nm. In vitro experiments in which the 2,2-diphenyl-1-picrylhydrazyl (DPPH) method was used to assess the prevalence of free radical-scavenging ability among these nanoparticles indicated that the loading efficiency for the nanoparticles was approximately 77.56%. Conclusion. Nanoparticles loaded with polyphenolic extract were obtained with average sizes ranging from (120 to 250) nm and largely spheroidal morphologies. Polymer and surfactant concentrations significantly influenced the hydrodynamic diameters and polydispersity indices of the particles. The incorporation of the polyphenolic extract into the polymer matrix enabled the preservation of the antiradical activity of the bioactive compound.

The objective of this study was to compare the efficiency of transfer of selenium (Se) to plasma and milk from inorganic sodium selenite, either free or microencapsulated, and from selenized yeast in dairy cows. The study consisted of an in situ-nylon bags incubation, and in an in vivo experiment to compare the Se status of cows supplemented with either sodium selenite, microencapsulated sodium selenite, or Se yeast. Thirty dairy cows, divided in five groups, were fed the following diets: the control group (CTR) received a total mixed ration supplemented with sodium selenite in order to have 0.3 mg/kg DM of total Se; 0.3M and 0.5M groups received the same control diet supplemented with lipid microencapsulated sodium selenite to provide 0.3 and 0.5 mg/kg DM of total Se, respectively; 0.3Y and 0.5Y groups received selenized yeast to provide 0.3 and 0.5 mg/kg of total Se, respectively. Cows were fed the supplements for 56 days during which milk, blood, and fecal samples were collected weekly to conduct analysis of Se and glutathione peroxidase (GSH-px) activity. Se concentration in the nylon bags was assessed to 72%, 64%, and 40% of the initial value (time 0) after 4, 8, and 24 h of incubation, respectively. In vivo, cows supplemented with 0.3 mg/kg of microencapsulated Se had higher milk Se concentration compared to CTR. The increment was more pronounced at the highest inclusion rate (0.5 mg/kg, 0.5M group). GSH-px activity was not significantly affected by treatments. The results indicate that lipid microencapsulation has the potential to protect nutrients from complete rumen reduction and that Se from microencapsulated selenite is incorporated in milk more efficiently than the free form. Microencapsulated sodium selenite was shown to be comparable to Se-yeast in terms of availability and incorporation in milk when fed at 0.3 mg/kg DM, whereas the inclusion in the diet at 0.5 mg/kg DM resulted in higher plasma and milk concentrations than selenized yeast.

Introduction. Camu-camu is a native Amazonian fruit mainly known for its high vitamin C content. Its composition confers high antioxidant capacity on this fruit and makes it a potential source of antioxidant products. The use of spray-drying with the aid of a carrier agent is a technique that has been applied for the preservation of important components of foods and drugs. The objective of our work was to evaluate the influence of those agents used as shell material on the vitamin content and total phenolic compounds of camu-camu powder juice obtained by spray-drying. Materials and methods. A commercial frozen camu-camu pulp was the raw material; maltodextrin and gum arabic were the selected carrier agents. Processes were performed in a mini-spray-dryer with inlet and outlet air temperatures of 180 °C and 85 °C, respectively, and a drying air flow rate of 700 L·h–1. Laser diffraction was used to determine the particle size distribution of the samples, and sorption isotherms of spray-dried camu-camu were measured using a static gravimetric method. Total phenolic compounds and vitamin C were determined in the raw pulp and in the powders obtained. Results. When using gum arabic and maltodextrin as the carrier agents, the moisture results obtained for the spray-dried camu-camu powders were 2.8% and 3.2%, respectively; the process yield was 84% and 72%, respectively. The spray-dried powder produced using gum arabic presented higher contents of vitamin C [(15,363 ± 226) mg·100 g–1] and phenolic compounds [(6,654 ± 596) mg GAE·100 g–1] than the powder obtained with maltodextrin, respectively (11,258 ± 298) mg·100 g–1 and (5,912 ± 582) mg GAE·100 g–1. Conclusions. The concentration factors for the vitamin C and phenolic compounds in camu-camu powder reveal the effectiveness of spray-drying to preserve the antioxidant capacity of this fruit. Gum arabic was a more effective barrier than maltodextrin for bioactive compound retention.

A need exists to prolong the release of rapidly metabolized peptides of a low molecular weight, while delivering this peptide without environmental interference. Previous studies have used bovine serum albumin (BSA) as a model peptide to study release characteristics from alginate microcapsules. BSA is 66 kDa in size, while the peptide of interest here, connexin-43 carboxyl-terminus mimetic peptide (αCT1), is only 3.4 kDa. Such a change in size results in a much different set of release parameters. Our overall goal is a sustained release over a 24+ h period. Prolonged application of the peptide to a wound site to investigate therapeutic effects is ideal. As a result, a diffusion method using alginate microcapsules, along with the addition of poly-l-lysine and poly-l-ornithine, has been explored. We first aimed to establish and characterize our parameters through a set of parametric tests. Variations in polymer coating, change in pH, and changes in loading ratio have previously been shown to effect release using model compounds. Here we test specific changes in these parameters to show effects on the release of αCT1. Additionally, the microcapsules were attached to several biomaterials and surgical implants by ultraviolet cross-linking to study the effectiveness of attachment and delivery. Analysis and measurements using phase contrast microscopy, scanning electron microscopy, and atomic force microscopy were used to characterize changes in microcapsule morphology.

The purpose of the present study was to evaluate the anti-hypercholesterolaemic effects of two putative probiotic bile salt hydrolase (Bsh)-producing Lactobacillusplantarum strains, i.e. Lp91 and Lp21, in rats. L. plantarum Lp91 exhibited excellent tolerance to low pH and high bile salt concentrations as well as showed potential Bsh activity, cholesterol assimilation and cholesterol co-precipitation ability along with L. plantarum Lp21 and NCDO82 strains. Furthermore, the potential effect of L. plantarum Lp91 on plasma cholesterol level was evaluated in Sprague–Dawley rats. Five treatment groups of rats (n 6) were fed experimental diets: normal diet, hypercholesterolaemic diet (HD), HD plus L. plantarum Lp91 (HD91) at ≥ 1·0 × 108 colony-forming units (cfu)/g, HD plus microencapsulated L. plantarum Lp91 (HDCap91) at ≥ 1·0 × 108 cfu/g and HD plus L. plantarum Lp21 (HD21) at ≥ 1·0 × 108 cfu/g for 3 weeks. Feed intake and feed efficiency differed significantly among the five groups. After 21 d of dietary treatment, comparative analysis revealed 23·26, 15·71 and 15·01 % reduction in total cholesterol, 21·09, 18·77 and 18·17 % reduction in TAG, 38·13, 23·22 and 21·42 % reduction in LDL-cholesterol, and the corresponding HDL-cholesterol values increased at the rate of 18·94, 10·30 and 7·78 % in treated groups HD91, HDCap91 and HD21, respectively. Faecal excretion of cholic acid and faecal lactobacilli counts were significantly higher in the probiotic treatment groups than in the control groups. In conclusion, these results suggest that the indigenous L. plantarum Lp91 strain has the potential to be explored as a probiotic in the management of hypercholesterolaemia.

The development of new functional foods requires technologies for incorporating health-promoting ingredients into food without reducing their bioavailability or functionality. In many cases, microencapsulation can provide the necessary protection for these compounds, but in all cases bioavailability should be carefully studied. The present paper gives an overview of the application of various microencapsulation technologies to nutritionally-important compounds, i.e. vitamins, n-3 polyunsaturated fatty acids, Ca, Fe and antioxidants. It also gives a view on future technologies and trends in microencapsulation technology for nutritional applications.

Zeolite, cellulose acetate phthalate (CAP) and maize starch were used as the coating materials for encapsulating pancreatic protease, which was proposed as an additive to enhance the food efficiency and growth rate of weanling pigs. In this study, microcapsules were formed by the process of coacervation in liquid paraffin media, where the deposition time was in the range of 20 to 60 min, and the concentrations of CAP, zeolite and maize starch were 20, 40 and 120 g/kg respectively. Hardening by n-hexane was achieved with 15 min of stirring. Microcapsules generated by this method were 20 to 30 mesh in diameter. They were stable for at least 3 h in simulated gastric conditions (pH 3·97), but disintegrated rapidly under simulated intestinal conditions (pH 6·82).